Tue, July 10, 2018
Mon, July 9, 2018
Fri, July 6, 2018
Thu, July 5, 2018
Tue, July 3, 2018
Mon, July 2, 2018
Fri, June 29, 2018

Robyn Karnauskas Upgraded (BIIB) to Strong Buy and Held Target at $371 on, Jul 6th, 2018

Robyn Karnauskas of Citigroup, Upgraded "Biogen Inc." (BIIB) to Strong Buy and Held Target at $371 on, Jul 6th, 2018.

Robyn has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 1 agrees with Robyn's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Downgraded from Buy to Hold on, Thursday, April 5th, 2018


These are the ratings of the 3 analyists that currently disagree with Robyn


  • Sumant Kulkarni of "Canaccord Genuity" Upgraded from Hold to Strong Buy on, Thursday, May 31st, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $369 on, Wednesday, April 25th, 2018
  • Brian Skorney of "Baird" Upgraded from Hold to Buy on, Wednesday, April 25th, 2018